Knowledge

Here you learn about the businesses and environment you’re working in. Knowing this, will help you to make better decisions and understand the bigger picture.

Current trends in data science for pharma – findings from a qualitative survey and what we should do about it!

Interview with Ursula Garczarek Do you want to learn where the health sector might be heading in terms of data science? Do you understand the opportunities and barriers in terms of the application of data science? Are you prepared to learn the individual skills needed for these changes? Then this interview with Ursula from Cytel …

Current trends in data science for pharma – findings from a qualitative survey and what we should do about it! Read More »

What you can learn about communication of statistics from a statistician working for the BBC

It’s surely not the norm, that a statistician from the pharma sector ends up working for BBC. But Robert Cuffe has taken this step and needs to explain statistics to non-statisticians on a daily basis. In this episode, he shares the different methods he’s using. We also dive into common pitfalls, that we as statisticians …

What you can learn about communication of statistics from a statistician working for the BBC Read More »

The rise of R and what role the AIMS SIG plays in it

Do you think, R can’t be used for regulatory submissions?Are you forced to use SAS but would like to use R instead?Would you like to understand how you can make R submission proof? Then this interview with Lyn Tailor and Craig McIlloney helps you. Both work on the PSI special interest group Application and Implementation …

The rise of R and what role the AIMS SIG plays in it Read More »

Getting access for patients to new medications in Germany – the biggest challenges in the HTA process and how to address them: Interview with Carsten Schwenke

Today, regulatory approval doesn’t ensure anymore, that patients benefit from new therapies. As statisticians, we also need to ensure access and reimbursement for new treatments in the different markets around the world. The process to gain this access and reimbursement in Germany comes with very specific challenges. Yet, due to the large impact of Germany …

Getting access for patients to new medications in Germany – the biggest challenges in the HTA process and how to address them: Interview with Carsten Schwenke Read More »

How to make the right portfolio decisions – Interview with Andreas Sashegyi

We’re all making decisions to optimize our studies. Optimizing project plans across different studies presents further challenges. But how to increase the overall portfolio of a company given its limitations leads yet another set of challenges. Knowing how decisions are taken at this top level helps to understand the bigger picture and why this sometimes …

How to make the right portfolio decisions – Interview with Andreas Sashegyi Read More »

Scroll to Top